Michael B. Andrews MD

Michael B. Andrews MD

Northwest Georgia Oncology Centers - Marietta

Education and Training

Specialty and Certification

Medical Oncology / Board Certified

Clinical Trial Cancer Types

Breast Cancer, Leukemia, Lung Cancer, Non-Hodgkin Lymphoma, Ovarian Cancer, Solid Tumor

Affiliations

Georgia CORE WellStar Kennestone Hospital
Northside Hospital

Active Clinical Trial Sites in Georgia

Northwest Georgia Oncology Centers - Marietta

340 Kennestone Hospital Boulevard
Suite 200
Marietta, GA 30060
770-281-5100 (p)
678-581-7109 (f)
www.ngoc.com

driving directions

Clinical Trials
An Open-Label, Multicenter Extension Study of Trastuzumab-MCC-DM1 (T-DM1) Administered as a Single Agent or in Combination With Other Anti-Cancer Therapies in Patients Previously Treated With the Equivalent T-DM1 Regimen in a Genentech and/or F. Hoffmann-La Roche Ltd.-Sponsored T-DM1 Study
Cancer Type: Breast Cancer

Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Of Fulvestrant (Faslodex®) With Or Without PD-0332991 (Palbociclib) +/- Goserelin In Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer Whose Disease Progressed After Prior Endocrine Therapy
Cancer Type: Breast Cancer

Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations. (OlympiAD)
Cancer Type: Breast Cancer

Connect® MDS/AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry
Cancer Type: Leukemia

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer Who Either Relapsed or Were Refractory to Prior Chemotherapy
Cancer Type: Lung Cancer

A Phase 3B Randomized Study of Lenalidomide (CC-5013) Plus Rituximab Maintenance Therapy Followed by Lenalidomide Single-agent Maintenance Versus Rituximab Maintenance in Subjects With Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma
Cancer Type: Non-Hodgkin Lymphoma

A Phase I, Open-label, Multiple-ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of MSB0010718C in Subjects With Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications
Cancer Type: Ovarian Cancer

Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 6 - BGJ398 for Patients With Tumors With FGFR Genetic Alterations
Cancer Type: Solid Tumor


WellStar Cobb Hospital

3950 Austell Road
Austell, GA 30106
770-732-4000 (p)
www.wellstar.org

driving directions



WellStar Douglas Hospital

8954 Hospital Drive
Douglasville, GA 30134
770-949-1500 (p)
www.wellstar.org

driving directions



WellStar Kennestone Hospital

677 Church Street
Marietta, GA 30060
770-793-5000 (p)
www.wellstar.org

driving directions



WellStar North Fulton Hospital

3000 Hospital Boulevard
Roswell, GA 30076
770-751-2500 (p)
www.wellstar.org

driving directions



WellStar Windy Hill Hospital

2540 Windy Hill Road
Marietta, GA 30067
770-644-1000 (p)
www.wellstar.org

driving directions

Active Clinical Trial Site Locations: